Earningsreport

Q1/2024 3/31/2024 EPS -0.110 ZacksConsensus -0.300 ActVsEst 0.190 - Beat

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors